upper waypoint

First Coronavirus Vaccine Could Come to Market Early Next Year

Save ArticleSave Article
Failed to save article

Please try again

People walk by the Pfizer world headquarters in New York on November 9, 2020. (KENA BETANCUR/AFP via Getty Images)

Early tests show that a coronavirus vaccine from drugmakers Pfizer and BioNTech could be 90 percent effective at preventing COVID-19, a disease that has now infected more than 10 million Americans and killed more than a million. While those results look promising, experts say the production and distribution of the vaccine — which needs to be kept at negative 80 degrees Celsius — will be complicated to say the least. Other challenges include convincing enough Americans to take the vaccine amid a climate of distrust and misinformation. Meanwhile, other drugmakers are also pushing to bring vaccines to the market. We’ll talk about the status of a coronavirus vaccine.

Guests:

Dr. Peter Chin-Hong, Infectious Disease Specialist, UCSF Medical Center

Meg Tirrell, senior health and science reporter, CNBC

Sponsored

lower waypoint
next waypoint